Castle Biosciences Stock Target Price and Analyst Consensus
| CSTL Stock | USD 18.91 0.37 2.00% |
The current analyst and expert consensus on Castle Biosciences is Strong Buy, with 8 strong buy opinions. The current projected Castle Biosciences target price consensus is 35.89 with 9 analyst opinions. Check out Macroaxis Advice on Castle Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.The most common way Castle Biosciences analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Castle Biosciences executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Castle Biosciences. We strongly encourage you to use your own analysis of Castle Biosciences to validate this buy or sell advice. Castle Biosciences buy-or-sell recommendation module provides average expert sentiment on the projected Castle Biosciences target price to derive its highest and lowest estimates based on projected price volatility of 2.9375.
Lowest Forecast 32.66 | Highest Forecast 39.84 | Target Price 35.89 |
It's important to approach Castle Biosciences' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Castle Biosciences Target Price Consensus
Castle target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Castle Biosciences' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 9 | Strong Buy |
Most Castle analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Castle stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Castle Biosciences, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationCastle Biosciences Target Price Projection
Castle Biosciences' current and average target prices are 18.91 and 35.89, respectively. The current price of Castle Biosciences is the price at which Castle Biosciences is currently trading. On the other hand, Castle Biosciences' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Castle Biosciences Market Quote on 20th of June 2025
Target Price
Analyst Consensus On Castle Biosciences Target Price
Castle Biosciences Analyst Ratings
Castle Biosciences' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Castle Biosciences stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Castle Biosciences' financials, market performance, and future outlook by experienced professionals. Castle Biosciences' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Castle Biosciences price targets
Castle Biosciences' stock target price is an estimate of its future price, usually made by analysts. Using Castle Biosciences' target price to determine if it is a suitable investment can be done through the following steps:- Look at Castle Biosciences' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Castle Biosciences' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Castle Biosciences Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Castle Biosciences is a key component of Castle Biosciences valuation and have some predictive power on the future returns of a Castle Biosciences.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Castle Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Computers Invested over 100 shares | |
 | Macroaxis Index Invested over 500 shares | |
 | Airlines Invested over 500 shares | |
 | Artificial Intelligence Invested over 500 shares | |
 | Corona Opportunity Invested few shares | |
 | ESG Investing Invested few shares | |
 | Business Services Invested few shares | |
 | Momentum Invested over 300 shares |
Check out Macroaxis Advice on Castle Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.